Heart disease Clinical Trials in Statesville, NC
As of June 2026, 5 paid clinical trials are recruiting for Heart disease in Statesville, North Carolina. Heart disease research tests new drug therapies, device-based interventions, and lifestyle programs for heart failure, atrial fibrillation, hypertension, and coronary disease — including therapies that reduce hospitalization and cardiovascular death. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
5 clinical trials for Heart disease
·Clear filters·↓ Download CSVZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
About research studies in Statesville
Statesville has approximately 36 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Top Research Study Locations in Statesville
Researchers run research studies in Statesville, NC at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Novant Health Cancer Institute - Statesville | Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative, Breast Cancer | 6 |
| Wake Forest Baptist Health - Hematology Oncology - Statesville | Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Extensive Stage Lung Small Cell Carcinoma | 4 |
| Accellacare of Piedmont HealthCare | Acute Treatment of Migraine, Chronic Idiopathic Constipation (CIC), Viral Respiratory Illnesses | 4 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Piedmont HealthCare, PA | Progressive Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Idiopathic Pulmonary Fibrosis (IPF) | 2 |
| Piedmont Healthcare | Cardiovascular Disease, Crohn's Disease, Ulcerative Colitis | 2 |
| Piedmont Healthcare/Research | Obesity, Osteoarthritis, Knee, Overweight | 2 |
| Piedmont Healthcare - Family Medicine | Chronic Obstructive Pulmonary Disease, Asthma | 2 |
| Accellacare - Piedmont | Acute Treatment of Migraine | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Novant Health Cancer Institute | Cervical Cancer | 1 |
| PHC Accelacare | Heart Failure, Obesity | 1 |
| Piedmont Health | Achondroplasia | 1 |
| Piedmont Healthcare LLC | Colo-rectal Cancer | 1 |
| Piedmont Healthcare Statesville | Diabetes Mellitus, Type 2 | 1 |
| Piedmont Healthcare, Inc. | Heart Failure | 1 |
Active & Upcoming Studies in Statesville (2026)
Recruiting trials in Statesville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (12 active studies)
- Shield Post-Approval Study Protocol · Guardant Health, Inc.
- Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy · Phase 3 · Eastern Cooperative Oncology Group
Diabetes & metabolic (7 active studies)
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Cardiovascular (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (1 active study)
Common conditions studied in Statesville
- Obesity (4 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Extensive Stage Lung Small Cell Carcinoma (2 active studies). Recruiting Extensive Stage Lung Small Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (2 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Overweight (2 active studies). Recruiting Overweight studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Progressive Pulmonary Fibrosis (2 active studies). Recruiting Progressive Pulmonary Fibrosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IIIB Lung Cancer AJCC v8 (2 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Statesville
- Novo Nordisk A/S
- AstraZeneca
- NRG Oncology
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Statesville. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Statesville
Hipa.ai aggregates every recruiting study in Statesville from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Statesville?
There are approximately 36 recruiting clinical trials in Statesville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Statesville pay participants?
Most recruiting trials in Statesville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Statesville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Statesville?
The most common conditions under active study in Statesville include Obesity (4), Extensive Stage Lung Small Cell Carcinoma (2), Heart Failure (2), Overweight (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Statesville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Statesville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Statesville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Statesville?
Recruiting research sites in Statesville include Novant Health Cancer Institute - Statesville, Wake Forest Baptist Health - Hematology Oncology - Statesville, Accellacare of Piedmont HealthCare, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Statesville right now?
The largest active categories in Statesville are Cancer & tumors (12), Diabetes & metabolic (7), Cardiovascular (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.